COA 2026: Advancing Innovative Cancer Care Through Community-Based Models

In this community oncology alliance (COA) pre-conference interview with Pharmacy Times, Christine Pfaff, RPh, MBA, discusses the growing importance of delivering innovative cancer therapies within community oncology settings. She emphasizes how medically integrated dispensing and pharmacy models enable close collaboration among pharmacists, physicians, nurses, and social workers to provide comprehensive, wraparound care for patients. Pfaff also outlines key barriers, particularly reimbursement challenges, noting the need for stronger communication between practices and payers to ensure appropriate recognition of the value being delivered. She explains that community oncology not only offers high-quality, cost-effective care but also allows patients to receive treatment closer to home with stronger support systems. The upcoming COA discussions will further explore strategies to improve payer relationships and ensure sustainable access to advanced therapies. You can view more coverage from COA here.